![1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole](https://veeprho.com/wp-content/uploads/2022/07/1-2-ethoxyethyl-2-1-nitrosopiperidin-4-yl-1H-benzo5Bd5Dimidazole.png)
1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole
1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole(CAS No: N/A) or 1-(2-methoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole,new-generation antihistamine and peripheral histamine H1-antagonist and used to treat seasonal allergic rhinitis and chronic spontaneous urticaria. The half-life of elimination is 14.5h and is 84-90% bound to plasma proteins.
Additional information on 1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole
Catalogue No.
VE009494
CAS No.
N/A
Molecular Formula
C16H22N4O2
Molecular Weight
302.37 g/mol
Parent drug
Bilastine
IUPAC Name
1-(2-ethoxyethyl)-2-(1-nitrosopiperidin-4-yl)-1H-benzo[d]imidazole
Synonyms
N/A
References
Ridolo, Erminia, et al. Bilastine: New Insight into Antihistamine Treatment.” Clinical and Molecular Allergy, vol. 13, no. 1, Apr. 2015, https://doi.org/10.1186/s12948-015-0008-x.
Status
In-stock
